⚑ This is your brand? Claim your page FREE and bring it to life on AI search.

Epalex Breakthrough Therapies for Migraine and Epilepsy

Epalex Breakthrough Therapies for Migraine and Epilepsy

Unclaimed

AEO Score: 4/10

Monitoring for AI engine activity

In the Engagemii AEO index

epalex.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Epalex Breakthrough Therapies for Migraine and Epilepsy just got measured.

4/10 means Epalex Breakthrough Therapies for Migraine and Epilepsy is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Epalex Breakthrough Therapies for Migraine and Epilepsy

Home Our Medicine Our Focus Our People Contact Us BREAKTHROUGH TREATMENTS WITH A DIFFERENCE Epalex is a clinical-stage pharmaceutical company developing breakthrough therapies for people with migraine and epilepsy.

Details

Industry: pharmaceuticals

Employees: 1-10

Founded: 2009

epalex.com

AI Visibility Breakdown

1

Structured Data

3

Content Structure

6

Entity Clarity

2

E-E-A-T Signals

5

Technical AEO

4

AI Discoverability

Is this your brand?

Claim free. You'll see:

βœ“

Your full 6-category score breakdown

βœ“

Exact fixes: robots.txt, schema, llms.txt

βœ“

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

βœ“

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Epalex Breakthrough Therapies for Migraine and Epilepsy: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Epalex Breakthrough Therapies for Migraine and Epilepsy.

Source & Attribution

Scored by Engagemii on June 25, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/epalex

Cite this score: Engagemii (2026). "AEO Score for Epalex Breakthrough Therapies for Migraine and Epilepsy." Retrieved from https://engagemii.com/aeo/brands/epalex

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform